An update on β-lactamase inhibitor discovery and development

JD Docquier, S Mangani - Drug Resistance Updates, 2018 - Elsevier
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance

RR Watkins, KM Papp-Wallace, SM Drawz… - Frontiers in …, 2013 - frontiersin.org
The increasing incidence and prevalence of multi-drug resistance (MDR) among
contemporary Gram-negative bacteria represents a significant threat to human health. Since …

Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use

D Carcione, C Siracusa, A Sulejmani, V Leoni, J Intra - Antibiotics, 2021 - mdpi.com
The β-lactams have a central place in the antibacterial armamentarium, but the increasing
resistance to these drugs, especially among Gram-negative bacteria, is becoming one of the …

β-Lactamase inhibitors: the story so far

FJ Perez-Llarena, G Bou - Current medicinal chemistry, 2009 - ingentaconnect.com
Antimicrobial resistance constitutes one of the major threats regarding pathogenic
microorganisms. Gramnegative pathogens, such as Enterobacteriaceae (specially those …

New β-lactam antibiotics and β-lactamase inhibitors

K Bush, MJ Macielag - Expert opinion on therapeutic patents, 2010 - Taylor & Francis
Importance of the field: β-Lactam antibiotics are among the most frequently prescribed
antibiotics used to treat bacterial infections. However, their utility is being threatened by the …

Three decades of β-lactamase inhibitors

SM Drawz, RA Bonomo - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Since the introduction of penicillin, β-lactam antibiotics have been the antimicrobial agents
of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened …

Beta-lactams and beta-lactamase-inhibitors in current-or potential-clinical practice: a comprehensive update

M Shahid, F Sobia, A Singh, A Malik… - Critical reviews in …, 2009 - Taylor & Francis
The use of successive generations of β-lactams has selected successive generations of β-
lactamases including CTX-M ESBLs, AmpC β-lactamases, and KPC carbapenamases in …

New β-lactamase inhibitors: a therapeutic renaissance in an MDR world

SM Drawz, KM Papp-Wallace… - Antimicrobial agents and …, 2014 - Am Soc Microbiol
As the incidence of Gram-negative bacterial infections for which few effective treatments
remain increases, so does the contribution of drug-hydrolyzing β-lactamase enzymes to this …

β-Lactams and β-lactamase inhibitors: an overview

K Bush, PA Bradford - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
β-Lactams are the most widely used class of antibiotics. Since the discovery of
benzylpenicillin in the 1920s, thousands of new penicillin derivatives and related β-lactam …

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria

K Bush, JF Fisher - Annual review of microbiology, 2011 - annualreviews.org
β-Lactamase evolution presents to the infectious disease community a major challenge in
the treatment of infections caused by multidrug-resistant gram-negative bacteria. Because …